A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
This bipartisan legislation prevents further cuts, provides a modest inflationary adjustment to help ease the cost of care, ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...